IG GLYCOSYLATION IN ULCERATIVE COLITIS: IT IS TIME FOR NEW BIOMARKERS

被引：0
|
作者：
Bertani, L. [1 ]
Capecchi, R. [1 ]
Migliorini, P. [1 ]
Zanzi, F. [1 ]
Puxeddu, I [1 ]
De Bortoli, N. [1 ]
Bellini, M. [1 ]
Costa, F. [2 ]
Marchi, S. [1 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Pisa Univ Hosp, Pisa, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2021年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
AF.44
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 50 条
  • [31] Biomarkers and Bowel Urgency in Response to Mirikizumab for Ulcerative Colitis
    Dubinsky, Marla C.
    Naegeli, April N.
    Shan, Mingyang
    Kayhan, Cem
    Milch, Catherine
    Schmitz, Jochen
    Bradesi, Sylvie
    Travis, Simon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S347 - S347
  • [32] Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative Colitis
    Clerc, Florent
    Reiding, Karli R.
    de Haan, Noortje
    Koeleman, Carolien A. M.
    Hipgrave Ederveen, Agnes L.
    Manetti, Natalia
    Dotz, Viktoria
    Annese, Vito
    Wuhrer, Manfred
    JOURNAL OF PROTEOME RESEARCH, 2023, 22 (10) : 3213 - 3224
  • [33] Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
    Pop, Corina Silvia
    Filip, Petruta Violeta
    Diaconu, Sorina Laura
    Matei, Clara
    Furtunescu, Florentina
    MEDICINA-LITHUANIA, 2021, 57 (01):
  • [34] Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia
    Beggs, Andrew D.
    James, Jonathan
    Caldwell, Germaine
    Prout, Toby
    Dilworth, Mark P.
    Taniere, Phillipe
    Iqbal, Tariq
    Morton, Dion G.
    Matthews, Glenn
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (07) : 1503 - 1509
  • [35] Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
    Wangchuk, Phurpa
    Yeshi, Karma
    Loukas, Alex
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (10) : 892 - 903
  • [36] Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis
    Galipeau, Heather J.
    Caminero, Alberto
    Turpin, Williams
    Bermudez-Brito, Miriam
    Santiago, Alba
    Libertucci, Josie
    Constante, Marco
    Garay, Juan Antonio Raygoza
    Rueda, Gaston
    Armstrong, Sarah
    Clarizio, Alex
    Smith, Michelle, I
    Surette, Michael G.
    Bercik, Premysl
    Croitoru, Kenneth
    Verdu, Elena F.
    GASTROENTEROLOGY, 2021, 160 (05) : 1532 - 1545
  • [37] Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis
    Kourkoulis, P.
    Kapizioni, C.
    Michalopoulos, G.
    Andreou, N. P.
    Papaconstantinou, I.
    Karamanolis, G.
    Gazouli, M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1173 - 1183
  • [38] Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
    Sakuraba, Akihito
    Nemoto, Nobuki
    Hibi, Noritaka
    Ozaki, Ryo
    Tokunaga, Sotaro
    Kikuchi, Oki
    Minowa, Shintaro
    Mitsui, Tatsuya
    Miura, Miki
    Saito, Daisuke
    Hayashida, Mari
    Miyoshi, Jun
    Matsuura, Minoru
    Yoneyama, Masayoshi
    Ohnishi, Hiroaki
    Hisamatsu, Tadakazu
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [39] Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach
    Assadsangabi, Arash
    Evans, Caroline A.
    Corfe, Bernard M.
    Lobo, Alan J.
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (05) : 808 - 819
  • [40] Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
    Akihito Sakuraba
    Nobuki Nemoto
    Noritaka Hibi
    Ryo Ozaki
    Sotaro Tokunaga
    Oki Kikuchi
    Shintaro Minowa
    Tatsuya Mitsui
    Miki Miura
    Daisuke Saito
    Mari Hayashida
    Jun Miyoshi
    Minoru Matsuura
    Masayoshi Yoneyama
    Hiroaki Ohnishi
    Tadakazu Hisamatsu
    BMC Gastroenterology, 21
12345